Yeji
CRLconf 0.92

zonisamide — CRL

$ETON · Eton Pharmaceuticals, Inc.
Event date
May 28, 2021
1835 days ago
Sponsor runway
cash-flow +
$19.7M liquid

Evidence

“Eton was notified that its partner received a Complete Response Letter("CRL") from the U.S. Food and Drug Administration ("FDA") regarding the New Drug Application for zonisamide oral suspension.”
Source: 8-K filed 2021-05-28View on EDGAR ↗0001493152-21-013245

Comparable historical crls· last 5 years · same event type

No comparable historical outcomes in our database yet — backfill of past readouts arrives next ingestion cycle.

Recent insider activity· ±90 days

3 insiders · 3 buys · 14 sells
Buy
2021-08-20
BRYNJELSEN SEAN
President & CEO
10,000 @ $4.32$43K
Buy
2021-08-20
Troutman William Wilson
CFO and Secretary
5,000 @ $4.43$22K
Sell
2021-08-06
Opaleye Management Inc.
10%+ Owner
15,000 @ $5.84$88K
Sell
2021-08-06
Opaleye Management Inc.
10%+ Owner
330,000 @ $5.84$1.93M
Sell
2021-08-05
Opaleye Management Inc.
10%+ Owner
150,000 @ $5.85$878K
Sell
2021-08-05
Opaleye Management Inc.
10%+ Owner
5,500 @ $5.85$32K
Sell
2021-08-04
Opaleye Management Inc.
10%+ Owner
100,000 @ $5.75$575K
Sell
2021-08-04
Opaleye Management Inc.
10%+ Owner
4,000 @ $5.75$23K
Sell
2021-06-15
Opaleye Management Inc.
10%+ Owner
4,000 @ $8.07$32K
Sell
2021-06-15
Opaleye Management Inc.
10%+ Owner
101,000 @ $8.07$815K
Buy
2021-06-03
BRYNJELSEN SEAN
President & CEO
5,000 @ $5.96$30K
Sell
2021-05-27
Opaleye Management Inc.
10%+ Owner
121,400 @ $8.49$1.03M
Sell
2021-05-27
Opaleye Management Inc.
10%+ Owner
4,600 @ $8.49$39K
Sell
2021-05-26
Opaleye Management Inc.
10%+ Owner
2,800 @ $8.57$24K
Sell
2021-05-26
Opaleye Management Inc.
10%+ Owner
65,500 @ $8.57$561K
Sell
2021-05-25
Opaleye Management Inc.
10%+ Owner
2,000 @ $8.53$17K
Sell
2021-05-25
Opaleye Management Inc.
10%+ Owner
46,000 @ $8.53$392K
← All catalysts for $ETON